Patents by Inventor Kevin G. Connors
Kevin G. Connors has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11197981Abstract: An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.Type: GrantFiled: April 23, 2020Date of Patent: December 14, 2021Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, Albert Chun-Chi Chin, Roy H. Sullivan, III, Matthew J. Whitney, William H. Gruber
-
Publication number: 20210128197Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: September 18, 2020Publication date: May 6, 2021Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
-
Publication number: 20200324091Abstract: An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.Type: ApplicationFiled: April 23, 2020Publication date: October 15, 2020Inventors: Kevin G. Connors, Albert Chun-Chi Chin, Roy H. Sullivan, III, Matthew J. Whitney
-
Patent number: 10799268Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: April 10, 2018Date of Patent: October 13, 2020Assignee: SOLACE THERAPEUTICS, INC.Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
-
Publication number: 20200253636Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: January 13, 2020Publication date: August 13, 2020Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
-
Publication number: 20200254226Abstract: An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.Type: ApplicationFiled: February 6, 2020Publication date: August 13, 2020Inventors: Kevin G. Connors, Albert Chum-Chi Chin, Roy H. Sullivan, III, Matthew J. Whitney, William H. Gruber
-
Publication number: 20200163543Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.Type: ApplicationFiled: July 3, 2019Publication date: May 28, 2020Inventors: Ernest George Schutt, Kevin G. Connors, John Gillespie, JR., Peter Dayton
-
Publication number: 20200146799Abstract: An inflated implant, such as an attenuation device, previously implanted in a urinary bladder can later be removed according to a number of different methods. Preferably, removal is accomplished transurethrally. In one embodiment, removal is accomplished by reducing the inflated implant from an enlarged profile to a reduced profile so that it may be withdrawn transurethrally by a removal system. The removal system can be configured differently depending upon whether reduction from the enlarged profile to the reduced profile is accomplished by deflation, compression, and/or other ways.Type: ApplicationFiled: June 17, 2019Publication date: May 14, 2020Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Publication number: 20200138556Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: June 17, 2019Publication date: May 7, 2020Inventors: Ryan J. Cahill, Scott Duncan, Kevin G. Connors, William H. Gruber, Sheila Caira
-
Publication number: 20200121342Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device can be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device can be inserted through the passageway created by the access device and can be used to deliver the pressure-attenuating device to the anatomical structure. The removal device can be inserted through the passageway created by the access device and can be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: August 30, 2019Publication date: April 23, 2020Inventors: Roy H. Sullivan, III, William H. Gruber, Albert Chum-Chi Chin, Nicole M. Shugrue, Kevin G. Connors, Matthew J. Witney
-
Patent number: 10543071Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: August 8, 2013Date of Patent: January 28, 2020Assignee: SOLACE THERAPEUTICS, INC.Inventors: Ryan J. Cahill, Scott Duncan, Kevin G. Connors, William Gruber, John Gillespie, Jr., Sheila Caira
-
Patent number: 10531894Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: September 20, 2017Date of Patent: January 14, 2020Assignee: Solace Therapeutics, Inc.Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
-
Patent number: 10383510Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.Type: GrantFiled: October 14, 2016Date of Patent: August 20, 2019Assignee: SOLACE THERAPEUTICS, INC.Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Jr., Peter Dayton
-
Patent number: 10327880Abstract: An inflated implant, such as an attenuation device, previously implanted in a urinary bladder can later be removed according to a number of different methods. Preferably, removal is accomplished transurethrally. In one embodiment, removal is accomplished by reducing the inflated implant from an enlarged profile to a reduced profile so that it may be withdrawn transurethrally by a removal system. The removal system can be configured differently depending upon whether reduction from the enlarged profile to the reduced profile is accomplished by deflation, compression, and/or other ways.Type: GrantFiled: August 29, 2016Date of Patent: June 25, 2019Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Publication number: 20180228512Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: April 10, 2018Publication date: August 16, 2018Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
-
Publication number: 20180193057Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: September 20, 2017Publication date: July 12, 2018Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
-
Publication number: 20170354491Abstract: An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal tip and an opening spaced from the tip to allow the implant to be released through the opening into an anatomical structure within the body.Type: ApplicationFiled: February 24, 2017Publication date: December 14, 2017Inventors: Kevin G. Connors, Hung Cao
-
Patent number: 9801658Abstract: Method and system for treating a patient using an inflatable device. A removal device may be used to remove the inflatable device from the body. The removal device can have at least one manually-actuatable member and at least two opposing jaws at a distal end. At least one of the at least two jaws can be movable by actuation of the at least one manually-actuatable member. At least one of the at least two jaws can have a puncturing member.Type: GrantFiled: March 27, 2015Date of Patent: October 31, 2017Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, Ryan J. Cahill
-
Publication number: 20170127929Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.Type: ApplicationFiled: October 14, 2016Publication date: May 11, 2017Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Peter Dayton
-
Patent number: 9615911Abstract: An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal tip and an opening spaced from the tip to allow the implant to be released through the opening into an anatomical structure within the body.Type: GrantFiled: February 20, 2015Date of Patent: April 11, 2017Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, Hung Cao